Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues.

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Abstract Text:

Danxin Wang,Audrey C Papp,Philip F Binkley,Julie A Johnson,Wolfgang ,

OBJECTIVES: The voltage-dependent L-type calcium channel alpha-subunit 1c (Cav1.2, CACNA1C) undergoes extensive mRNA splicing, leading to numerous isoforms with different functions. L-type calcium channel blockers are used in the treatment of hypertension and arrhythmias, but response varies between individuals. We have studied the interindividual variability in mRNA expression and splicing of CACNA1C, in 65 heart tissue samples, taken from heart transplant recipients. METHODS: Splice variants were measured quantitatively by polymerase chain reaction in 12 splicing loci of CACNA1C mRNA. To search for functional cis-acting polymorphisms, we determined allelic expression ratios for total CACNA1C mRNA and several splice variants using marker single nucleotide polymorphisms in exon 4 and exon 30. RESULTS: Total CACNA1C mRNA levels varied approximately 50-fold. Substantial splicing occurred in six loci generating two or more splice variants, some with known functional differences. Splice patterns varied broadly between individuals. Two heart tissues expressed predominantly the dihydropyridine-sensitive smooth muscle isoform of CACNA1C (containing exon 8), rather than the cardiac isoform (containing exon 8a). Lack of significant allelic expression imbalance, observed with total mRNA and several splice variants, argued against CACNA1C polymorphisms as a cause of variability. Taken together, highly variable splicing can cause profound phenotypic variations of CACNA1C function, potentially associated with disease susceptibility and response to L-type calcium channel blockers.

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Publishing Authors By Initials

D Wang,AC Papp,PF Binkley,JA Johnson,W ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pharmacogenetics and genomics

VOLUME: 16

Page Numbers: 735-45

Journal Abbreviation:

ISSN: 1744-6872

DAY: 26

MONTH: Oct

YEAR: 2006

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101231005

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues.

AFFILIATION: Program in Pharmacogenomics, Departments of aPharmacology bInternal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio cCenter for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pharmacogenet Genomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues Related Publications

• Autoradiography of lambda binding sites in rat brain.
• Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.
• Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.
• Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
• Genotyping panel for assessing response to cancer chemotherapy.
• Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues.
• MicroRNA expression profiles for the NCI-60 cancer cell panel.
• MicroRNAs modulate the chemosensitivity of tumor cells.
• Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.
• Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.
• Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.
• The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.